The Effect of Laughter Yoga on Primiparous Pregnant Women
ConditionLaughter
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorBozok University
About this trial
Primiparous women constitute a special risk group who may experience higher levels of fear of childbirth and lower birth self-efficacy during pregnancy due to their lack of prior childbirth experience. Fear of childbirth is associated with increased anxiety, negative birth experiences, and unnecessary medical interventions, while birth self-efficacy is an important determinant of adaptation to the birth process and positive birth outcomes. In recent years, non-pharmacological and mind-body-based interventions have become increasingly important in the management of these psychological problems. Laughter yoga is a complementary method that combines conscious laughter exercises with breathing techniques to reduce stress and anxiety. This randomized controlled trial aims to evaluate the effect of laughter yoga on fear of childbirth and self-efficacy during childbirth in primiparous pregnant women. The study aims to provide scientific evidence for the use of laughter yoga as an effective, safe, and inexpensive psychosocial intervention that can be applied in prenatal care.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Being 18 years of age or older,
never having given birth before
be a primiparous pregnant woman experiencing her first birth,
be pregnant with a single baby,
Disqualifiers
A diagnosis of high-risk pregnancy or the presence of serious obstetric complications that prevent participation in exercise (e.g., placenta previa, uncontrolled gestational hypertension or preeclampsia, bed rest recommended due to threatened preterm labor, cervical insufficiency),
multiple pregnancy,
history of recurrent pregnancy loss (≥2 miscarriages) or pregnancy achieved through assisted reproductive techniques (e.g., IVF),
diagnosis of a known psychiatric disorder (major depression, anxiety disorder, psychosis, etc.),
Trial design
Design model
Parallel
Treatments tested in this trial
Laughter yoga
BehavioralSessions will consist of warm-up and breathing exercises, guided intentional laughter exercises, diaphragmatic breathing and relaxation, followed by a short mindfulness and closing phase.
Treatment groups
110 Participants
are divided into 2 treatment groupsGroup A: LaughterExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Wijma Childbirth Expectation/Experience Questionnaire - Version A (W-DEQ/ Version A)
It was developed by Klaas and Barbro Wijma to measure women's fear of childbirth. The scale consists of 33 items. Responses on the scale are numbered from 0 to 5 and are on a six-point Likert scale. 0 means "completely," and 5 means "not at all." The minimum score on the scale is 0, while the maximum score is 165. As the score increases, so does the fear of childbirth experienced by women. While the first version of the scale did not specify a score range, subsequent studies determined a scoring range. This range can be used when interpreting scale scores. The total item score is interpreted as 0-60 for low fear of childbirth, 61-84 for moderate fear of childbirth, and 85 and above for high fear of childbirth.
Time frame
Baseline (Day 0) and Week 4Secondary outcomes
1
Self-Efficacy Scale in Childbirth (SEB-C32)
The Self-Efficacy Scale for Childbirth was developed by Lowe (1993) to assess women's confidence and coping ability during childbirth. The short version of the scale was later developed by Ip et al. The Turkish validity and reliability study was conducted by Ersoy, with a Cronbach's alpha coefficient of 0.90. The scale consists of two subscales-outcome expectation and efficacy expectation-each comprising 16 items. Total scores range from 32 to 320, with higher scores indicating greater self-efficacy for childbirth. Items are rated on a 10-point Likert scale, with higher scores reflecting higher perceived competence and positive outcome expectations.
Time frame
Baseline (Day 0) and Week 4Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: